Literature DB >> 16401837

Vascular endothelial growth factor and POEMS.

Peter J Dyck, JaNean Engelstad, Angela Dispenzieri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16401837     DOI: 10.1212/01.wnl.0000194614.56025.ec

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

1.  Clinical reasoning: a 40-year-old man with CIDP-like illness resistant to treatment.

Authors:  Rajat Lahoria; Chafic Karam; Angela Dispenzieri; P James B Dyck
Journal:  Neurology       Date:  2013-09-03       Impact factor: 9.910

Review 2.  Chronic inflammatory demyelinating polyneuropathies: current treatment strategies.

Authors:  Thomas B Toothaker; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

3.  Pulmonary morbidity improves after autologous stem cell transplantation in POEMS syndrome.

Authors:  Satish Chandrashekaran; Angela Dispenzieri; Stephen S Cha; Cassie C Kennedy
Journal:  Respir Med       Date:  2014-11-14       Impact factor: 3.415

4.  Nerve pathologic features differentiate POEMS syndrome from CIDP.

Authors:  Ezequiel A Piccione; Janean Engelstad; Peter J Dyck; Michelle L Mauermann; Angela Dispenzieri; P James B Dyck
Journal:  Acta Neuropathol Commun       Date:  2016-10-31       Impact factor: 7.801

Review 5.  An update on the diagnosis and management of the polyneuropathy of POEMS syndrome.

Authors:  Federica Cerri; Yuri Matteo Falzone; Nilo Riva; Angelo Quattrini
Journal:  J Neurol       Date:  2018-09-27       Impact factor: 4.849

6.  Prognostic value of serum vascular endothelial growth factor and hematological responses in patients with newly-diagnosed POEMS syndrome.

Authors:  Hao Zhao; Hao Cai; Chen Wang; Xu-Fei Huang; Xin-Xin Cao; Lu Zhang; Dao-Bin Zhou; Jian Li
Journal:  Blood Cancer J       Date:  2018-04-04       Impact factor: 11.037

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.